279 related articles for article (PubMed ID: 24858230)
21. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
22. Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells.
Verma V; Sharma V; Singh V; Sharma S; Bishnoi AK; Chandra V; Maikhuri JP; Dwivedi A; Kumar A; Gupta G
Toxicol Appl Pharmacol; 2014 Oct; 280(2):323-34. PubMed ID: 25123791
[TBL] [Abstract][Full Text] [Related]
23. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
24. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
Miyazaki H; Watabe T; Kitamura T; Miyazono K
Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
[TBL] [Abstract][Full Text] [Related]
25. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.
Burchardt T; Burchardt M; Chen MW; Cao Y; de la Taille A; Shabsigh A; Hayek O; Dorai T; Buttyan R
J Urol; 1999 Nov; 162(5):1800-5. PubMed ID: 10524938
[TBL] [Abstract][Full Text] [Related]
26. Hexim-1 modulates androgen receptor and the TGF-β signaling during the progression of prostate cancer.
Mascareno EJ; Belashov I; Siddiqui MA; Liu F; Dhar-Mascareno M
Prostate; 2012 Jun; 72(9):1035-44. PubMed ID: 22095517
[TBL] [Abstract][Full Text] [Related]
27. Phthalates deregulate cell proliferation, but not neuroendocrine transdifferentiation, in human LNCaP prostate cancer cell model.
Hrubá E; Pernicová Z; Pálková L; Souček K; Vondráček J; Machala M
Folia Biol (Praha); 2014; 60 Suppl 1():56-61. PubMed ID: 25369342
[TBL] [Abstract][Full Text] [Related]
28. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
[TBL] [Abstract][Full Text] [Related]
29. Molecular and toxicologic research in newborn hypospadiac male rats following in utero exposure to di-n-butyl phthalate (DBP).
Zhu YJ; Jiang JT; Ma L; Zhang J; Hong Y; Liao K; Liu Q; Liu GH
Toxicology; 2009 Jun; 260(1-3):120-5. PubMed ID: 19464577
[TBL] [Abstract][Full Text] [Related]
30. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
31. Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells.
Thelen P; Peter T; Hünermund A; Kaulfuss S; Seidlová-Wuttke D; Wuttke W; Ringert RH; Seseke F
BJU Int; 2007 Jul; 100(1):199-203. PubMed ID: 17488304
[TBL] [Abstract][Full Text] [Related]
32. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
Steiner H; Godoy-Tundidor S; Rogatsch H; Berger AP; Fuchs D; Comuzzi B; Bartsch G; Hobisch A; Culig Z
Am J Pathol; 2003 Feb; 162(2):655-63. PubMed ID: 12547723
[TBL] [Abstract][Full Text] [Related]
33. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling.
Verona EV; Elkahloun AG; Yang J; Bandyopadhyay A; Yeh IT; Sun LZ
Cancer Res; 2007 Jun; 67(12):5737-46. PubMed ID: 17575140
[TBL] [Abstract][Full Text] [Related]
35. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation of estrogen receptor alpha gene by phthalates.
Kang SC; Lee BM
J Toxicol Environ Health A; 2005 Dec; 68(23-24):1995-2003. PubMed ID: 16326419
[TBL] [Abstract][Full Text] [Related]
37. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
van der Poel HG
Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
[TBL] [Abstract][Full Text] [Related]
39. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
[TBL] [Abstract][Full Text] [Related]
40. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]